Pseudomyxoma peritonei - Symptoms, signs and clinical differential diagnosis

CME Journal of Gynecologic Oncology

Volumn 8, Issue 2, 2003, Pages 199-203

  Mukherjee, Arijit ^a   Moran, Brendan J ^a  

^a NORTH HAMPSHIRE HOSPITAL   (United Kingdom)

Author keywords

Clinical presentation; Differential diagnosis; Pseudomyxoma peritonei

Indexed keywords

ABDOMINAL PRESSURE; APPENDICITIS; APPENDIX PERFORATION; APPENDIX TUMOR; ASCITES; CANCER STAGING; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CYSTADENOCARCINOMA; CYSTADENOMA; DIFFERENTIAL DIAGNOSIS; FEMALE; GASTROINTESTINAL TUMOR; HUMAN; INCIDENCE; LAPAROTOMY; MAJOR CLINICAL STUDY; MALE; OVARY TUMOR; PERITONEUM PSEUDOMYXOMA; REVIEW; SYMPTOMATOLOGY;

EID: 0142259765     PISSN: 12199087     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (21)

1. Fann JI, Vierra M, Fisher D, et al. Pseudomyxoma peritonei. Surg Gynecol Obstet 1993; 177:441-447.
2. Werth R, Klinische and Anastomische Untersuchungen Zur Lehrc von der Bauchgeschwullsten and der Laparotomie. Arch Gynecol Obstet 1884; 100-118.
3. Frankel E, Uher das sogenanute pseudomyxoma peritonei. Med Wochenschr 1901; 48:965-970.
4. Hinson FL, Ambrose NS. Pseudomyxoma peritonei. Br J Surg 1998; 332-339.
5. Sherer DM, Abulafia O, Eliakim R. Pseudomyxoma peritonei: a review of current literature. Gynecol Obstet Invest 2001; 51:73-80.
6. Young RH, Scully RE. Ovarian metastasis from the carcinoma of gall bladder and extra hepatic bile ducts simulating primary tumour of ovary. A report of six cases. Int J Gynecol Pathol 1990; 9:60-72.
7. Ikejiri K, Anai H, Kitmura K, Yakabe S, Saku M, Yoshida K. Pseudomyxoma peritonei concomitant with early gastric cancer: report of a case. Surg Today 1996; 26:923-925.
8. Jones CM, Homesley HD. Successful treatment of pseudomyxoma peritonei of ovarian origin with cisplatinum, doxorubicin, and cyclophosphomide. Gynecol Oncol 1985; 22:257-259.
9. Feinstein AR, Sosin DM, Wells CK. The Will Rogers phenomenon: stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N Eng J Med 1985; 312:1604.
10. Ronnett BM, Zahn CM, Kurman RJ, et al. Disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis: A clinicopathological analysis of 109 cases with emphasis on distinguishing pathologic features, site of origin, prognosis, and relationoship to "pseudomyxoma peritonei". Am J Surg Pathol 1995; 19:1390-1408.
11. Sugarbaker PH, Ronnett BM, Archer A, Averbach AM, et al. Pseudomyxoma peritonei syndrome. Advances in Surgery. 1997; 30:233-280. Mosby-Year Book, Inc.
12. Esqviel J, Sugarbaker PH. Clinical presentation of Pseudomyxoma peritonei syndrome. Br J Surg 2000; 87:1414-1418.
13. Walensky RP, Venbrux AC, Prescott CA, Osterman FA Jr. Pseudomyxoma peritonei: AJR. Am J Roentgenol 1996; 167:471-474.
14. Balthazar EJ, Javors BR. The radiology corner. Pseudomyxoma peritonei: clinical and radiographic features. Am J Gastroenterol 1977; 68:501-509.
15. Jacquet P, Jelinek J, Sugarbaker PH. Use of abdominal computerized tomogram to select peritoneal carcinomatosis patients for the cytoreductive approach. J Am Coll Surg 1995; 181:530-538.
16. Russell N, Low, Robert Barone CP Sebrechts. Peritoneal tumour: MR imaging with dilute oral barium and intravenous gadolinium-containing contrast agents compared with unenhanced MR imaging and CT. Radiology 1997; 204:513-520.
17. Gollub MJ, DeCorato, Schwartz PE. MR enteroclysis: evaluation of small bowel obstruction in a patient with pseudomyxoma peritonei. AJR 2000; 174:688-690.
18. Pugh DG. A roentgenologic aspect of pseudomyxoma peritonei. Radiology 1942; 39:320-322.
19. Sulkin TVC, Oneill H, Amin AI, Moran B. CT in pseudomyxoma peritonei: A review of 17 cases. Clin Radiol 2002; 57:608-613.
20. Yu W, Ilwoo W, Young Chung H, et al. Indications for early postoperative chemotherapy of advanced gastric cancer: results of a prospective randomized trial. World J Surg 2001; 25:985-990.
21. Alexander-Sefre F, Chandrakumaran K, Banerjee S, Cecil T, Moran B. An elevated CEA does not preclude complete tumour removal in advanced pseudomyxoma peritonei but indicates an increased risk of recurrence. Br J Surg 2003; 90(Suppl.1):78.